We are live on
!
Find out more
TSW
Thompson Siegel & Walmsley Portfolio holdings
AUM
$5.7B
1-Year Est. Return
6.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$7.3B
AUM Growth
+$297M
(+4.2%)
Cap. Flow
-$50.3M
Cap. Flow
% of AUM
-0.69%
Top 10 Holdings %
Top 10 Hldgs %
17.43%
Holding
817
New
58
Increased
143
Reduced
218
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$86.7M |
| 2 |
Graphic Packaging
GPK
|
+$49.8M |
| 3 |
Flex
FLEX
|
+$46.9M |
| 4 |
Old Republic International
ORI
|
+$46M |
| 5 |
NVR
NVR
|
+$40.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$92.1M |
| 2 |
Bunge Global
BG
|
+$50.3M |
| 3 |
Leidos
LDOS
|
+$39.3M |
| 4 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$38.5M |
| 5 |
NCR Voyix
VYX
|
+$34.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.68% |
| 2 | Technology | 12.23% |
| 3 | Healthcare | 9.96% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Utilities | 9.65% |
Similar funds
PI
ACM
VH
O
XT
DCP
HW
AAM
Thompson Siegel & Walmsley's Q2 2021 Portfolio in Review
As of Q2 2021, Thompson Siegel & Walmsley held 817 positions worth $7.3B, up 4.2% from $7.01B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Thompson Siegel & Walmsley's Q2 2021 filing shows 58 new, 143 increased, 218 reduced and 72 closed positions. Its largest new stake was Organon & Co: 2,634,306 shares worth $79.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.1M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- Thompson Siegel & Walmsley's largest Q2 2021 buy was Organon & Co: 2,634,306 shares worth $79.7M.
- Thompson Siegel & Walmsley added most to Graphic Packaging in Q2 2021, an estimated $49.8M increase.
- Thompson Siegel & Walmsley's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $92.1M.
- Thompson Siegel & Walmsley fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $38.5M.
- Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $7.3B portfolio in Q2 2021.
- Thompson Siegel & Walmsley opened 58 new positions and closed 72 in Q2 2021.
- Thompson Siegel & Walmsley's portfolio value rose 4.2% quarter-over-quarter to $7.3B.
Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.